The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice
Open accessAbstract
Serotonin receptors of the 5-HT(2A) subtype are robustly expressed in the cerebral cortex where they have been implicated in the pathophysiology and therapeutics of mental disorders and the actions of hallucinogens. Much less is known, however, about the specific cell types expressing 5-HT(2A) receptors in cortex. In the current study we use immunohistochemical and electrophysiological approaches in genetically modified mice to address the expression of the Htr2a gene and 5-HT(2A) receptors in cortex. We first use an EGFP-expressing BAC transgenic mice and identify three main Htr2A gene expressing neuronal populations in cortex. The largest of these cell populations corresponds to layer V pyramidal cells of the anterior cortex, followed by GABAergic interneurons of the middle layers, and non-pyramidal cells of the subplate/Layer VIb. We then use 5-HT(2A) receptor knockout mice to identify an antibody capable of localizing 5-HT(2A) receptors in brain and use it to map these receptors. We find strong laminar expression of 5-HT(2A) receptors in cortex, especially along a diffuse band overlaying layer Va. This band exhibits a strong anteroposterior gradient that closely matches the localization of Htr2A expressing pyramidal cells of layer V. Finally we use electrophysiological and immunohistochemical approaches to show that most, but not all, GABAergic interneurons of the middle layers are parvalbumin expressing Fast-spiking interneurons and that these cells are depolarized and excited by serotonin, most likely through the activation of 5-HT(2A) receptors. These results clarify and extend our understanding of the cellular distribution of 5-HT(2A) receptors in the cerebral cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,211
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex
The Petilla Interneuron Nomenclature Group (PING) (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2402 · Cited by 1,491
GABAergic cell subtypes and their synaptic connections in rat frontal cortex
Kawaguchi, Y. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.476 · Cited by 1,416
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Cited by
Sorted by citations
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Corticostriatal connectivity and its role in disease
Shepherd, G. M. G. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3469 · Cited by 824
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 499
Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits
Puig, M. V., & Gulledge, A. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8214-0 · Cited by 421
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Nutt, D., King, L. A., & Nichols, D. E. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3530 · Cited by 355
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 274
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0718-8 · Cited by 258
Central 5-HT receptors and their function; present and future
Sharp, T., & Barnes, N. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108155 · Cited by 239
Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
Lord, L.-D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K. M., Lambiotte, R., Nutt, D., Deco, G., Carhart-Harris, R. L., Kringelbach, M. L., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.05.060 · Cited by 221
Canal, C. E., & Morgan, D. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1333 · Cited by 234
Distinct Eligibility Traces for LTP and LTD in Cortical Synapses
He, K., Huertas, M. A., Hong, S. Z., Tie, X., Hell, J. W., Shouval, H. Z., & Kirkwood, A. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.037 · Cited by 220
Viñals, X., Moreno, E., Lanfumey, L., Cordomí, A., Pastor, A., de la Torre, R., Gasperini, P., Navarro, G., Howell, L. A., Pardo, L., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002194 · Cited by 209
Millière, R. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00245 · Cited by 206
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166
Serotonergic regulation of neuronal excitability in the prefrontal cortex
Andrade, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.015 · Cited by 167
Subcircuit-specific neuromodulation in the prefrontal cortex
Dembrow, N. C., & Johnston, D. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00054 · Cited by 141
Selective serotonergic excitation of callosal projection neurons
Avesar, D., & Gulledge, A. T. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00012 · Cited by 122
Sanz, C., Zamberlán, F., Erowid, E., Erowid, F., & Tagliazucchi, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00007 · Cited by 113
Benekareddy, M., Goodfellow, N. M., Lambe, E. K., & Vaidya, V. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3245-10.2010 · Cited by 96
Clock Genes Control Cortical Critical Period Timing
Kobayashi, Y., Ye, Z., & Hensch, T. K. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.036 · Cited by 99
Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Cameron, L. P., Benetatos, J., Lewis, V., Bonniwell, E. M., Jaster, A. M., Moliner, R., Ċastrén, E., McCorvy, J. D., Palner, M., & Aguilar‐Valles, A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1384-23.2023 · Cited by 100
Michaiel, A. M., Parker, P. R. L., & Niell, C. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.104 · Cited by 82
Psychedelics and Neural Plasticity: Therapeutic Implications
Grieco, S. F., Castrén, E., Knudsen, G. M., Kwan, A. C., Olson, D. E., Zuo, Y., Holmes, T. C., & Xu, X. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1121-22.2022 · Cited by 82
Martin, D. A., & Nichols, C. D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.049 · Cited by 93
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Stoliker, D., Egan, G. F., Friston, K. J., & Razi, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000508 · Cited by 96
An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress
Lu, J., Tjia, M., Mullen, B., Cao, B., Lukasiewicz, K., Shah-Morales, S., Weiser, S., Cameron, L. P., Olson, D. E., Chen, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01159-1 · Cited by 84
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O’Keane, V., et al. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02668-2 · Cited by 84
Yadav, P. N., Kroeze, W. K., Farrell, M. S., & Roth, B. L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183780 · Cited by 82
Lambe, E. K., Fillman, S. G., Webster, M. J., & Weickert, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022799 · Cited by 83
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex
Nocjar, C., Alex, K. D., Sonneborn, A., Abbas, A. I., Roth, B. L., & Pehek, E. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.050 · Cited by 82
G protein-coupled receptor heteromers are key players in substance use disorder
Derouiche, L., & Massotte, D. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.026 · Cited by 76
Therapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 70
Guirado, R., Sanchez-Matarredona, D., Varea, E., Crespo, C., Blasco‐Ibáñez, J. M., & Nácher, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-5 · Cited by 70
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Delille, H. K., Mezler, M., & Marek, G. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.005 · Cited by 68
Roth, B. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.012 · Cited by 68
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 72
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
Jones, S. V., & O’Kelly, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00034 · Cited by 68
Li, L., Zhang, L., He, Z., Ma, H., Zhang, Y., Xun, Y., Yuan, W., Hou, W., Li, Y.-T., Lv, Z., et al. (2021) · eLife · doi:10.7554/elife.67638 · Cited by 66
Serotonin Regulates Performance Nonmonotonically in a Spatial Working Memory Network
Cano-Colino, M., Almeida, R., Gómez-Cabrero, D., Artigas, F., & Compte, A. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht096 · Cited by 58
Bánlaki, Z., Elek, Z., Nánási, T., Székely, A., Nemoda, Z., Sasvári‐Székely, M., & Rónai, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117792 · Cited by 58
Sargin, D., Jeoung, H.-S., Goodfellow, N. M., & Lambe, E. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00073 · Cited by 54
Neuromodulatory control of complex adaptive dynamics in the brain
Shine, J. M. (2023) · Interface Focus · doi:10.1098/rsfs.2022.0079 · Cited by 58
Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input
Azimi, Z., Barzan, R., Spoida, K., Surdin, T., Wollenweber, P., Mark, M. D., Herlitze, S., & Jancke, D. (2020) · eLife · doi:10.7554/elife.53552 · Cited by 57
The Effects of Hallucinogens on Gene Expression
Martin, D. A., & Nichols, C. D. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_479 · Cited by 59
Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
Buchborn, T., Lyons, T., & Knöpfel, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00017 · Cited by 50
Athilingam, J. C., Ben-Shalom, R., Keeshen, C. M., Sohal, V. S., & Bender, K. J. (2017) · eLife · doi:10.7554/elife.31991 · Cited by 49
Lotter, L. D., Kohl, S. H., Gerloff, C., Bell, L., Niephaus, A., Kruppa, J. A., Dukart, J., Schulte‐Rüther, M., Reindl, V., & Konrad, K. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105042 · Cited by 52
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_107 · Cited by 50
Rijsketic, D. R., Casey, A. B., Barbosa, D. A. N., Zhang, X., Hietamies, T. M., Ramirez-Ovalle, G., Pomrenze, M. B., Halpern, C. H., Williams, L. M., Malenka, R. C., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01613-4 · Cited by 46
Endogenous Serotonin 5-HT2A and 5-HT2C Receptors Associate in the Medial Prefrontal Cortex
Price, A. E., Sholler, D. J., Stutz, S. J., Anastasio, N. C., & Cunningham, K. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00669 · Cited by 47
Hallucinogen actions on human brain revealed
Lee, H.-M., & Roth, B. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121358109 · Cited by 46
Santana, N., Mengod, G., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001083 · Cited by 45
The Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder
Maia, T. V., & Cano-Colino, M. (2015) · Clinical Psychological Science · doi:10.1177/2167702614566809 · Cited by 42
Proenneke, A., Witte, M., Möck, M., & Staiger, J. F. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz102 · Cited by 50
Kirkcaldie, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10004-4 · Cited by 45
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R., Lees, A. J., Young, A. H., & Rucker, J. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320912125 · Cited by 39
Catalysts for change: the cellular neurobiology of psychedelics
Banks, M. I., Zahid, Z., Jones, N., Sultan, Z. W., & Wenthur, C. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-05-0340 · Cited by 45
Williams, A. A., Ingram, W. M., Levine, S., Resnik, J., Kamel, C. M., Lish, J. R., Elizalde, D. I., Janowski, S. A., Shoker, J., Kozlenkov, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.81 · Cited by 37
Developmental profiles of infant EEG: Overlap with transient cortical circuits
Myers, M. M., Grieve, P. G., Wallach, A. I., Fifer, W. P., Isler, J. R., Darnall, R. A., & Stark, R. I. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.11.264 · Cited by 37
Pehrson, A. L., Jeyarajah, T., & Sánchez, C. (2015) · CNS Spectrums · doi:10.1017/s1092852915000486 · Cited by 38
Stephens, E. K., Avesar, D., & Gulledge, A. T. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00097 · Cited by 36
Yin, L., Rasch, M. J., He, Q., Wu, S., Dou, F., & Shu, Y. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv245 · Cited by 34
Filippo, R. D., Rost, B. R., Stumpf, A., Cooper, C., Tukker, J. J., Harms, C., Beed, P. S., & Schmitz, D. (2021) · eLife · doi:10.7554/elife.66960 · Cited by 34
The Effects of Psychedelics on Neuronal Physiology
Hatzipantelis, C. J., & Olson, D. E. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-020923 · Cited by 39
Predictive Processing: A Circuit Approach to Psychosis
Keller, G. B., & Sterzer, P. (2024) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100223-121214 · Cited by 45
Htr2a Expression Responds Rapidly to Environmental Stimuli in an Egr3-Dependent Manner
Maple, A. M., Zhao, X., Elizalde, D. I., McBride, A. K., & Gallitano, A. L. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00031 · Cited by 31
Buchborn, T., Schröder, H., Dieterich, D. C., Grecksch, G., & Höllt, V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.014 · Cited by 29
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 33
Rozas, C., Loyola, S., Ugarte, G., Zeise, M. L., Reyes-Parada, M. I., Pancetti, F. C., Rojas, P., & Morales, B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.11.010 · Cited by 28
Wyskiel, D. R., & Andrade, R. (2016) · Hippocampus · doi:10.1002/hipo.22611 · Cited by 29
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
Herian, M., Skawski, M., Wojtas, A., Sobocińska, M. K., Noworyta, K., & Gołembiowska, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05860-5 · Cited by 26
Contreras, A., Hines, D. J., & Hines, R. M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00154 · Cited by 25
Zhao, X., Ozols, A. B., Meyers, K. T., Campbell, J. M., McBride, A., Marballi, K. K., Maple, A. M., Raskin, C., Mishra, A. P., Noss, S., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01390-w · Cited by 24
Nonaka, H., Mino, T., Sakamoto, S., Oh, J. H., Watanabe, Y., Ishikawa, M., Tsushima, A., Amaike, K., Kiyonaka, S., Tamura, T., et al. (2022) · Chem · doi:10.1016/j.chempr.2022.11.005 · Cited by 24
Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study
Wang, D., & Wong‐Lin, K. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00054 · Cited by 24
Häggkvist, J., Tóth, M., Tari, L., Varnäs, K., Svedberg, M. M., Forsberg, A., Nag, S., Dominguez, C., Muñoz-Sanjuán, I., Bard, J., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180497 · Cited by 24
Yu, W., Yen, Y.-C., Lee, Y., Tan, S., Xiao, Y., Lokman, H., Ting, A. K. T., Ganegala, H. E. W., Kwon, T., Ho, W., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0452-5 · Cited by 27
5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
Nakao, K., Singh, M., Sapkota, K., Fitzgerald, A., Hablitz, J. J., & Nakazawa, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01930-0 · Cited by 21
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 24
Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention
Tian, M. K., Schmidt, E. F., & Lambe, E. K. (2016) · eNeuro · doi:10.1523/eneuro.0269-16.2016 · Cited by 26
Hámor, P. U., Šírová, J., Páleníček, T., Zaniewska, M., Bubeníková‐Valešová, V., & Schwendt, M. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.09.007 · Cited by 22
Morozova, A. Y., Zorkina, Y., Ka, P., Pavlova, O., Storozheva, Z. I., Zubkov, E. A., Zakharova, N. V., Karpenko, O., Reznik, A. M., Chekhonin, V. P., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00830 · Cited by 20
Stephens, E. K., Baker, A. L., & Gulledge, A. T. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00002 · Cited by 19
Herian, M., Wojtas, A., Sobocińska, M. K., Skawski, M., González-Marín, A., & Gołembiowska, K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00181-4 · Cited by 19
Role of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice
Hideshima, K. S., Hojati, A., Saunders, J. M., On, D. M., Revenga, M. D. L. F., Shin, J. M., Sánchez-González, A., Dunn, C. M., Pais, A. B., Pais, A. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5015-4 · Cited by 19
Bombardi, C., Delicata, F., Tagliavia, C., Pierucci, M., Deidda, G., Casarrubea, M., Deurwaerdère, P. D., & Giovanni, G. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051873 · Cited by 17
Genetic modulation of the HTR2A gene reduces anxiety-related behavior in mice
Rohn, T. T., Radin, D. I., Brandmeyer, T., Linder, B., Andriambeloson, E., Wagner, S., Kehler, J., Vasileva, A., Wang, H., Mee, J. L., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad170 · Cited by 19
Layer-specific serotonergic facilitation of IPSC in layer 2/3 pyramidal neurons of the visual cortex
Jang, H., Cho, K., Park, S., Kim, M.-J., Yoon, S. H., & Rhie, D. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00535.2011 · Cited by 17
Distribution of 5-HT receptors in the central nervous system: an update
Vilaró, M., Cortės, R., Mengod, G., & Hoyer, D. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00006-2 · Cited by 15
Puzerey, P. A., Decker, M. J., & Galán, R. F. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00031.2014 · Cited by 16
Cellular rules underlying psychedelic control of prefrontal pyramidal neuronsPreprint
Ekins, T. G., Brooks, I. A. W., Kailasa, S., Rybicki-Kler, C., Jedrasiak‐Cape, I., Donoho, E., Mashour, G. A., Rech, J. C., & Ahmed, O. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.20.563334 · Cited by 19
Ionescu, T. M., Amend, M., Watabe, T., Hatazawa, J., Maurer, A., Reischl, G., Pichler, B. J., Wehrl, H. F., & Herfert, K. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264391 · Cited by 16
Synthetic surprise as the foundation of the psychedelic experience
Filippo, R. D., & Schmitz, D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105538 · Cited by 17
Using melanopsin to study G protein signaling in cortical neurons
McGregor, K. M., Bécamel, C., Marin, P., & Andrade, R. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00406.2016 · Cited by 16
Metadata
- Authors
- Weber
- Affiliations
- Wayne State University (US)
- Corresponding author
- Weber
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2010
- Volume
- 4
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC2928707
- OpenAlex
- W2166045982
- Cited by
- 205
- References
- 53
- Citations by year
- 2026: 16 · 2025: 10 · 2024: 16 · 2023: 17 · 2022: 17 · 2021: 17 · 2020: 13 · 2019: 14 · 2018: 12 · 2017: 8 · 2016: 9 · 2015: 16 · 2014: 9 · 2013: 9 · 2012: 8
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R01MH043985)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- HTR2A, 5-HT2A receptor, cerebral cortex, serotonin receptors, cortical cell types, layer 5 pyramidal neurons, GABAergic interneurons, parvalbumin interneurons, fast-spiking interneurons, receptor knockout mice, BAC transgenic mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review